EQS-News: ABIVAX / Key word (s): Annual Results Abivax Announces Full Year 2024 Financial Results 24.03.2025 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement.

Based on the currently available funds and the expected reimbursement of the research tax credits (CIR) from 2024 in the second half of 2025 amounting to EUR 5.7M, Abivax expects to be able to finance ...

iBusiness Funding, which acquired Funding Circle in 2024, is an online lender that offers small-business loans of up to $500,000. These term loans can be a good option for established business ...

CTIM-76 first patient dosed in January 2025Cash and cash equivalents of $94.4 million as of December 31, 2024Company expects its cash and cash ...

Q4 2024 Earnings Call Transcript March 19, 2025 Williams-Sonoma, Inc. beats earnings expectations. Reported EPS is $3.28, ...

The series, published in the San Francisco Chronicle, shows how hundreds of officers used clean-record agreements to conceal ...

Q4 2024 Earnings Conference Call March 18, 2025 10:00 AM ETCompany ParticipantsBrandon Mintz - CEOScott Buchanan - COO ...

The chaos at the Internal Revenue Service began almost immediately after the first envoy from the Department of Government ...

U.S. Court of Appeals for the Second Circuit considered whether allegations of a prison officer’s destruction of a prisoner’s ...

Couche-Tard Chief Executive Alex Miller said Thursday that the company has a good track record with antitrust authorities around the world, and has successfully closed many deals in the U.S. He said ...